160 related articles for article (PubMed ID: 15566641)
21. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr].
Zhao C; Zheng XL; Yan YY; Song H; Li DX; Yang L; Qin Y; Lin Y; Wang X; Liao LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):893-7. PubMed ID: 25571710
[TBL] [Abstract][Full Text] [Related]
22. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
[TBL] [Abstract][Full Text] [Related]
23. Annosquacin B induces mitochondrial apoptosis in multidrug resistant human breast cancer cell line MCF-7/ADR through selectively modulating MAPKs pathways.
Yuan F; Bai G; Miao Y; Chen Y; Li X; Chen J
Pharm Biol; 2016 Dec; 54(12):3040-3045. PubMed ID: 27450387
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
[TBL] [Abstract][Full Text] [Related]
25. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
[TBL] [Abstract][Full Text] [Related]
26. [Effect of ursolic acid on caspase-3 and PARP expression of human MCF-7 cells].
Zhang GP; Lu YY; Lv JC; Ou HJ
Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(2):141-4. PubMed ID: 16570804
[TBL] [Abstract][Full Text] [Related]
27. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
[TBL] [Abstract][Full Text] [Related]
28. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
[TBL] [Abstract][Full Text] [Related]
29. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
30. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
31. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein.
Liu Z; Zhu H; Qu S; Tang L; Cao L; Yu W; Yang X; Jiang S; Zhu D; Tan C; Yu L
Anticancer Agents Med Chem; 2018; 18(2):286-294. PubMed ID: 28782465
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells.
Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J
Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765
[TBL] [Abstract][Full Text] [Related]
33. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
35. The anti-hepatitis drug DDB chemosensitizes multidrug resistant cancer cells in vitro and in vivo by inhibiting P-gp and enhancing apoptosis.
Jin J; Sun H; Wei H; Liu G
Invest New Drugs; 2007 Apr; 25(2):95-105. PubMed ID: 16937080
[TBL] [Abstract][Full Text] [Related]
36. [Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells].
Chen YY; Li J; Hu JD; Zheng J; Zheng ZH; Zhu LF; Chen XJ; Lin ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1413-22. PubMed ID: 24370022
[TBL] [Abstract][Full Text] [Related]
37. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
38. [Reversal effect of peptide-modified chitosan tetramethylpyrazine nanoparticles on multidrug resistance in tumor cells].
Xiang-Yang L; Qing F; Chen-Yang Z; Ming-Kun S; Hui MA; Li-Chun C; Ren Bao Li Gao A; Zhen-Long YU
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5487-5494. PubMed ID: 33350210
[TBL] [Abstract][Full Text] [Related]
39. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
[TBL] [Abstract][Full Text] [Related]
40. FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo.
Deng WJ; Yang XQ; Liang YJ; Chen LM; Yan YY; Shuai XT; Fu LW
Acta Pharmacol Sin; 2007 Jun; 28(6):913-20. PubMed ID: 17506952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
